We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 153

Patentability of algorithm using historical data for a portion of its calculations decided in Bio-Rad case on 24 July 2017
  • Watermark Intellectual Property
  • Australia
  • August 10 2017

The case of Bio-Rad Laboratories, Inc. 2017 APO 38 was decided on 24 July 2017 by the Australian Patent Office and decided that computer-implemented


Survey of the Safe Harbor in the United States and Europe
  • Fish & Richardson PC
  • USA, Australia, United Kingdom, European Union
  • December 7 2016

On October 3, 2016, the United States Supreme Court denied Amphastar Pharmaceutical's petition for certiorari regarding the so-called "safe harbor,"


US FDA Issues Guidance On The Of Use Next Generation Sequencing In Precision Medicine
  • Watermark Intellectual Property
  • USA, Australia
  • August 8 2016

The United States Food and Drug Administration (FDA) has recently released two draft guidance documents on the use of high-throughput DNA sequencing


The importance of good laboratory notebook practice
  • Davies Collison Cave
  • USA, Australia
  • October 18 2011

Take note: poor laboratory notebook documentation could cost you!


Biotech data exclusivity and biogenerics
  • Davies Collison Cave
  • Australia
  • March 29 2011

As reported in our legal briefing of March 2010, the US House of Representatives passed legislation to provide the biotechnology industry with a 12-year period of exclusivity for data relating to new biologics.




Lynn L. Bergeson
  • Bergeson & Campbell PC